Published journal articles indexed by SCI, SSCI, and AHCI
Articles Published in Other Journals
Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats
TÜRKİYE PARAZİTOLOJİ DERGİSİ
, vol.42, pp.39-80, 2018 (Peer-Reviewed Journal)
Refereed Congress / Symposium Publications in Proceedings
S1P1 Agonisti SEW2871 insan Th17 Hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir
XXIV. Ulusal İmmünoloji Kongresi, Turkey, 27 - 30 April 2017
Detailed Immonological Analysıis of Recombinant Crimean Congo Hemorrhagic Fever Virus Nucleoprotein
European Congress of Virology, 28 April - 01 May 2019
Fingolimod ve SEW2871 insan Th17 hücresi gelişimini etkilemektedir
10.Klinik Nöroimmunoloji Sempozyumu, Girne, Cyprus (Kktc), 1 - 05 April 2018, pp.34
Discovery of Crimean‐Congo Hemorrhagic Fever Virus vaccine candidate antigens by protein microarray scanning and verification of the determined antigens by recombinant ELISA
2017 ISV Annual Congress, 5 - 07 October 2017

Protein Mikroarray Tarama ile Kırım-Kongo Kanamalı Ate şi Virüsüneait a şı adayı antijenlerin ke şfi ve rekombinant ELISA ile do ğrulanması
20. Ulusal Parazitoloji Kongresi(Uluslararası Katılımlı), 25 - 29 September 2017
Evaluation of CCHFV nucleoprotein as diagnostic tool in ELISA
2nd International Conference on Crimean-Congo Hemorrhagic Fever, 10 - 12 September 2017
S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions
IMMUNOLOGY2017, Washington Dc, United States Of America, 12 - 16 May 2017, vol.198
Direct and indirect effects of S1P1 Agonist SEW2871 on human Th17 cell generation and functions
Erciyes Tıp Genetik Günleri, Kayseri, Turkey, 11 - 15 May 2017
S1P1 Agonisti SEW2871’in insan Th17 hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir
XXIV. Ulusal İmmunoloji Kongresi, İstanbul, Turkey, 27 - 30 April 2017
Kırım Kongo Aşı Projesi
37. Türk Mikrobiyoloji Kongresi, Turkey, 16 - 20 November 2016

Investigation of IFN Response to the Inactivated Vaccine Developed against Crimean Congo Hemorrhagic Fever Virus
9th Vaccine & ISV Annual Global Congress, 18 - 20 October 2015

Investigation of IFN gama Response to the Inactivated Vaccine Developed against Crimean Congo Hemorrhagic Fever Virus
9th Vaccine and ISV Congress, 18 - 20 October 2015

KIRIM KONGO KANAMALI HASTALIGINA KARSI HUCRE KULTUR TABANLI ASI GELISTIRME CALISMALARI
ASI BILIMI KONGRESI, İzmir, Turkey, 28 - 30 April 2015
Immunization of knock out alpha beta interferon receptor mice against high lethal dose of Crimean Congo hemorrhagic fever virus with a cell culture based vaccine
CSCM-World Congress on CBRNe Science and Consequence Management, Zagreb, Croatia, 12 - 17 April 2015

AŞI ÇALIŞMALARI
2. ULUSAL KLİNİK ARAŞTIRMALAR KONGRESİ, Turkey, 27 - 28 March 2015

A Purified Inactivated Crimean-Congo Hemorrhagic Fever Virus Vaccine Derived from Vero Cells
7th Vaccine&ISV Congress, Barcelona, Spain, 27 - 29 October 2013, pp.92

Crimean-Congo Hemorrhagic Fever Infection prevalance in Field Collected Ticks in Endemic Areas of Turkey
5th European Congress of Virology, Lyon, France, 11 - 14 September 2013, pp.189
İndirekt ELISA Testi ile Sığır, Koyun ve Keçilerde Kırım-Kongo Kanamalı Ateşi Hastalığı Virusunun Seroprevalansının Belirlenmesi
X. Ulusal Veteriner Hekimleri Mikrobiyoloji Kongresi, Aydın, Turkey, 24 - 27 September 2012, pp.101
Endemik Bölgede Konak Arayan Kenelerde Kırım-Kongo Kanamalı Ateşi Virüsünün Yaygınlığı
4. Ulusal Viroloji Kongresi, İstanbul, Turkey, 23 - 26 June 2011